These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 31960032)
1. "Rapid Start" Treatment to End the (Other) Epidemic: Walking the Tightrope Without a Net. Eaton EF Clin Infect Dis; 2021 Feb; 72(3):479-481. PubMed ID: 31960032 [No Abstract] [Full Text] [Related]
2. Impact of Medications for Opioid Use Disorder on Discharge Against Medical Advice Among People Who Inject Drugs Hospitalized for Infective Endocarditis. Suzuki J; Robinson D; Mosquera M; Solomon DA; Montgomery MW; Price CD; Johnson JA; Martin B; Liebschutz JW; Schnipper JL; Weiss RD Am J Addict; 2020 Mar; 29(2):155-159. PubMed ID: 31930608 [TBL] [Abstract][Full Text] [Related]
3. We Thought We Created a Safety Net. We Were Wrong. Eaton EF Clin Infect Dis; 2021 Oct; 73(7):e1658-e1660. PubMed ID: 32881991 [No Abstract] [Full Text] [Related]
4. Provider-directed marketing may increase prescribing of medications for opioid use disorder. Nguyen T; Andraka-Christou B; Simon K; Bradford WD J Subst Abuse Treat; 2019 Sep; 104():104-115. PubMed ID: 31370974 [TBL] [Abstract][Full Text] [Related]
5. An Integrated Hospital Protocol for Persons With Injection-Related Infections May Increase Medications for Opioid Use Disorder Use but Challenges Remain. Eaton EF; Lee RA; Westfall AO; Mathews RE; McCleskey B; Paddock CS; Lane PS; Cropsey KL J Infect Dis; 2020 Sep; 222(Suppl 5):S499-S505. PubMed ID: 32877555 [TBL] [Abstract][Full Text] [Related]
6. In Fighting An Opioid Epidemic, Medication-Assisted Treatment Is Effective But Underused. Vestal C Health Aff (Millwood); 2016 Jun; 35(6):1052-7. PubMed ID: 27269022 [No Abstract] [Full Text] [Related]
7. Medications for addiction treatment initiated from the emergency department: Ethical considerations. Marshall KD; Derse AR; Iserson KV; Kluesner N; Vearrier L Am J Emerg Med; 2020 Feb; 38(2):343-348. PubMed ID: 31831343 [No Abstract] [Full Text] [Related]
8. Leveraging pharmacists to maintain and extend buprenorphine supply for opioid use disorder amid COVID-19 pandemic. Peckham AM; Ball J; Colvard MD; Dadiomov D; Hill LG; Nichols SD; Tallian K; Ventricelli DJ; Tran TH Am J Health Syst Pharm; 2021 Mar; 78(7):613-618. PubMed ID: 33411894 [TBL] [Abstract][Full Text] [Related]
9. How Family Physicians Can Combat the Opioid Epidemic. Middleton JL Am Fam Physician; 2017 Sep; 96(6):357-358. PubMed ID: 28925644 [No Abstract] [Full Text] [Related]
10. Beliefs about medications for opioid use disorder among Florida criminal problem-solving court & dependency court staff. Andraka-Christou B; Atkins D Am J Drug Alcohol Abuse; 2020 Nov; 46(6):749-760. PubMed ID: 32969757 [TBL] [Abstract][Full Text] [Related]
11. Implementation and evaluation of Missouri's Medication First treatment approach for opioid use disorder in publicly-funded substance use treatment programs. Winograd RP; Wood CA; Stringfellow EJ; Presnall N; Duello A; Horn P; Rudder T J Subst Abuse Treat; 2020 Jan; 108():55-64. PubMed ID: 31277891 [TBL] [Abstract][Full Text] [Related]
12. The provision of counseling to patients receiving medications for opioid use disorder: Telehealth innovations and challenges in the age of COVID-19. Hughto JMW; Peterson L; Perry NS; Donoyan A; Mimiaga MJ; Nelson KM; Pantalone DW J Subst Abuse Treat; 2021 Jan; 120():108163. PubMed ID: 33298301 [TBL] [Abstract][Full Text] [Related]
13. Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic. Cochran G; Bruneau J; Cox N; Gordon AJ Subst Abus; 2020; 41(3):269-274. PubMed ID: 32697171 [TBL] [Abstract][Full Text] [Related]
14. Putting Parity into Practice - Integrating Opioid-Use Disorder Treatment into the Hospital Setting. Fanucchi L; Lofwall MR N Engl J Med; 2016 Sep; 375(9):811-3. PubMed ID: 27579631 [No Abstract] [Full Text] [Related]
15. Comparing Reasons for Starting and Stopping Methadone, Buprenorphine, and Naltrexone Treatment Among a Sample of White Individuals With Opioid Use Disorder. Randall-Kosich O; Andraka-Christou B; Totaram R; Alamo J; Nadig M J Addict Med; 2020; 14(4):e44-e52. PubMed ID: 31651562 [TBL] [Abstract][Full Text] [Related]
16. Utilization of buprenorphine and methadone among opioid users who inject drugs. Tsui JI; Burt R; Thiede H; Glick SN Subst Abus; 2018 Jan; 39(1):83-88. PubMed ID: 28796591 [TBL] [Abstract][Full Text] [Related]
17. Challenges to implementing opioid substitution therapy in Ukrainian prisons: Personnel attitudes toward addiction, treatment, and people with HIV/AIDS. Polonsky M; Azbel L; Wickersham JA; Taxman FS; Grishaev E; Dvoryak S; Altice FL Drug Alcohol Depend; 2015 Mar; 148():47-55. PubMed ID: 25620732 [TBL] [Abstract][Full Text] [Related]
18. Impact of a jail-based treatment decision-making intervention on post-release initiation of medications for opioid use disorder. Banta-Green CJ; Williams JR; Sears JM; Floyd AS; Tsui JI; Hoeft TJ Drug Alcohol Depend; 2020 Feb; 207():107799. PubMed ID: 31865058 [TBL] [Abstract][Full Text] [Related]
19. Deploying science to change hearts and minds: Responding to the opioid crisis. Walsh SL; Long KQX Prev Med; 2019 Nov; 128():105780. PubMed ID: 31319116 [TBL] [Abstract][Full Text] [Related]
20. Association of Treatment With Medications for Opioid Use Disorder With Mortality After Hospitalization for Injection Drug Use-Associated Infective Endocarditis. Kimmel SD; Walley AY; Li Y; Linas BP; Lodi S; Bernson D; Weiss RD; Samet JH; Larochelle MR JAMA Netw Open; 2020 Oct; 3(10):e2016228. PubMed ID: 33052402 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]